Cheryl L. Walker

6.6k total citations · 1 hit paper
24 papers, 2.0k citations indexed

About

Cheryl L. Walker is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Cheryl L. Walker has authored 24 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Reproductive Medicine, 10 papers in Obstetrics and Gynecology and 8 papers in Molecular Biology. Recurrent topics in Cheryl L. Walker's work include Endometriosis Research and Treatment (11 papers), Uterine Myomas and Treatments (9 papers) and Tuberous Sclerosis Complex Research (4 papers). Cheryl L. Walker is often cited by papers focused on Endometriosis Research and Treatment (11 papers), Uterine Myomas and Treatments (9 papers) and Tuberous Sclerosis Complex Research (4 papers). Cheryl L. Walker collaborates with scholars based in United States, Japan and Denmark. Cheryl L. Walker's co-authors include Gordon B. Mills, Jeffrey I. Everitt, Jiyong Liang, Zhiyong Ding, Jordan U. Gutterman, Bryan T. Hennessy, Seiji Kondo, Joyce M. Slingerland, Michelle D. Larrea and Zhixiang Xu and has published in prestigious journals such as Nature Cell Biology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Cheryl L. Walker

24 papers receiving 2.0k citations

Hit Papers

The energy sensing LKB1–AMPK pathway regulates p27kip1 ph... 2007 2026 2013 2019 2007 200 400 600

Peers

Cheryl L. Walker
Cheryl L. Walker
Citations per year, relative to Cheryl L. Walker Cheryl L. Walker (= 1×) peers Jean Guibourdenche

Countries citing papers authored by Cheryl L. Walker

Since Specialization
Citations

This map shows the geographic impact of Cheryl L. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl L. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl L. Walker more than expected).

Fields of papers citing papers by Cheryl L. Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl L. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl L. Walker. The network helps show where Cheryl L. Walker may publish in the future.

Co-authorship network of co-authors of Cheryl L. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl L. Walker. A scholar is included among the top collaborators of Cheryl L. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl L. Walker. Cheryl L. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crabtree, Judy S., Scott A. Jelinsky, Heather A. Harris, et al.. (2009). Comparison of Human and Rat Uterine Leiomyomata: Identification of a Dysregulated Mammalian Target of Rapamycin Pathway. Cancer Research. 69(15). 6171–6178. 83 indexed citations
2.
Lu, Karen H., Weiguo Wu, Bhuvanesh Dave, et al.. (2008). Loss of Tuberous Sclerosis Complex-2 Function and Activation of Mammalian Target of Rapamycin Signaling in Endometrial Carcinoma. Clinical Cancer Research. 14(9). 2543–2550. 55 indexed citations
3.
Short, John D., Kevin D. Houston, Ruhee Dere, et al.. (2008). AMP-Activated Protein Kinase Signaling Results in Cytoplasmic Sequestration of p27. Cancer Research. 68(16). 6496–6506. 46 indexed citations
4.
Woodruff, Teresa K. & Cheryl L. Walker. (2008). Fetal and early postnatal environmental exposures and reproductive health effects in the female. Fertility and Sterility. 89(2). e47–e51. 37 indexed citations
5.
Crain, D. Andrew, Sarah Janssen, Thea M. Edwards, et al.. (2008). Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertility and Sterility. 90(4). 911–940. 336 indexed citations
6.
Liang, Jiyong, Shan Shao, Zhixiang Xu, et al.. (2007). The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis. Nature Cell Biology. 9(2). 218–224. 712 indexed citations breakdown →
7.
Takeda, Takashi, Masahiro Sakata, Akira Miyake, et al.. (2007). Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation. Human Reproduction. 23(2). 440–446. 37 indexed citations
8.
Walker, Cheryl L.. (2002). Role of Hormonal and Reproductive Factors in the Etiology and Treatment of Uterine Leiomyoma. PubMed. 57(1). 277–294. 57 indexed citations
9.
Walker, Cheryl L., et al.. (2001). Protective effect of pregnancy for development of uterine leiomyoma. Carcinogenesis. 22(12). 2049–2052. 38 indexed citations
10.
Hunter, Deborah, Leslie Hodges-Gallagher, Patricia K. Eagon, et al.. (2000). Influence of Exogenous Estrogen Receptor Ligands on Uterine Leiomyoma: Evidence from an in Vitro/in Vivo Animal Model for Uterine Fibroids. Environmental Health Perspectives. 108(s5). 829–834. 37 indexed citations
11.
Lau, Serrine S., Terrence J. Monks, Jeffrey I. Everitt, Elena Kleymenova, & Cheryl L. Walker. (2000). Carcinogenicity of a Nephrotoxic Metabolite of the “Nongenotoxic” Carcinogen Hydroquinone. Chemical Research in Toxicology. 14(1). 25–33. 52 indexed citations
12.
Perera, Ayesh D., Elena Kleymenova, & Cheryl L. Walker. (2000). Requirement for the von Hippel-Lindau tumor suppressor gene for functional epidermal growth factor receptor blockade by monoclonal antibody C225 in renal cell carcinoma.. PubMed. 6(4). 1518–23. 37 indexed citations
13.
Burroughs, Kevin D., Robin Fuchs‐Young, Barbara J. Davis, & Cheryl L. Walker. (2000). Altered Hormonal Responsiveness of Proliferation and Apoptosis During Myometrial Maturation and the Development of Uterine Leiomyomas in the Rat1. Biology of Reproduction. 63(5). 1322–1330. 71 indexed citations
14.
Fuchs‐Young, Robin, S R Howe, Laura V. Hale, Rebecca R. Miles, & Cheryl L. Walker. (1996). Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators. Molecular Carcinogenesis. 17(3). 151–159. 61 indexed citations
15.
Howe, S R, Jeffrey I. Everitt, Marco M. Gottardis, & Cheryl L. Walker. (1995). Estrogen/Antiestrogen Responsiveness in an In Vivo/In Vitro Model for Myometrial Tumorigenesis. Annals of the New York Academy of Sciences. 761(1). 373–375. 10 indexed citations
16.
Howe, S R, Marco M. Gottardis, Jeffrey I. Everitt, & Cheryl L. Walker. (1995). Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo.. Endocrinology. 136(11). 4996–5003. 90 indexed citations
17.
Recio, Leslie, et al.. (1995). p53 status in spontaneous and dimethylnitrosamine—induced renal cell tumors from rats. Molecular Carcinogenesis. 12(4). 236–240. 14 indexed citations
18.
Walker, Cheryl L., et al.. (1992). Possible cellular and molecular mechanisms for asbestos carcinogenicity. American Journal of Industrial Medicine. 21(2). 253–273. 69 indexed citations
19.
Patterson, R, et al.. (1989). Prednisonephobia. Allergy and Asthma Proceedings. 10(6). 423–428. 22 indexed citations
20.
Nettesheim, Paul, D J Fitzgerald, Hitoshi Kitamura, et al.. (1987). In vitro analysis of multistage carcinogenesis.. Environmental Health Perspectives. 75. 71–79. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026